Actelion (Actelion) Total Stockholders Equity : $1,610 Mil (As of Mar. 2017)

View and export this data going back to . Start your Free Trial

What is Actelion Total Stockholders Equity?

Actelion's Total Stockholders Equity for the quarter that ended in Mar. 2017 was $1,610 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Actelion's Book Value per Share for the quarter that ended in Mar. 2017 was $15.39. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Actelion's Debt-to-Equity for the quarter that ended in Mar. 2017 was 0.00.

Actelion Total Stockholders Equity Historical Data

The historical data trend for Actelion's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Total Stockholders Equity Chart

Actelion Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Total Stockholders Equity

Get a 7-Day Free Trial

1,648.37

1,913.13

1,969.06

1,324.29

1,300.27

Actelion Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Total Stockholders Equity	Get a 7-Day Free Trial															1,453.92	1,389.14	1,349.75	1,300.27	1,610.46

Actelion (OTCPK:ALIOF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Actelion's Book Value per Share for the quarter that ended in Mar. 2017 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1610.463	-	0)	/	104.638
	=	15.39

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Actelion's Debt-to-Equity for the quarter that ended in Mar. 2017 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	1610.463
	=	0.00

Actelion Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Actelion's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Actelion (Actelion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (OTCPK:ALIOF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.actelion.com

Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (Actelion) Headlines

From GuruFocus

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 01-24-2017

Jean Hynes Reduces Stake in Actelion

By Kyle Ferguson Kyle Ferguson • 08-03-2016

Actelion Still On Growth Track

By reports.droy reports.droy • 02-18-2015

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 02-14-2017